Prasugrel
Detailed Description
Prasugrel with CAS 150322-43-3 is a platelet inhibitor for acute coronary syndromes planned for percutaneous coronary intervention.
Prasugrel (CAS 150322-43-3), Prasugrel is a prodrug and is rapidly metabolized to a pharmacologically active metabolite and inactive metabolites. The active metabolite has an elimination half-life of about 7 hr (range 2-15 hr). Healthy subjects, patients with stable atherosclerosis, and patients undergoing PCI show similar pharmacokinetics.
View Contact Detail